Allogene Therapeutics Earnings
NASDAQ: ALLOHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
1.46+0.06 (+4.29%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Thu, Nov 5, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.13
Allogene Therapeutics earnings summary
Allogene Therapeutics is scheduled to report Sep/2026 earnings on Nov 5, 2026, with analysts expecting EPS of $-0.13.
Summary generated from market data by MetaCap's automated system. Methodology